fundings GenMark Dx Bought by Roche for $1.8B by FBT Team March 15, 2021 written by FBT Team March 15, 2021 Carlsbad-based GenMark has been purchased by testing giant, Roche, for $1.8 Billion. GenMark makes tests that detect multiple pathogens simultaneously including pneumonia and sepsis. Roche has likely acquired GenMark to challenge rivals functioning in this space. Read more here. 0 comment 0 LinkedinFacebookTwitterEmail FBT Team previous post TritonTech: Barometer next post Prometheus Biosciences Raises $190M Related Articles IoT startup Wiliot raises $200 million from SoftBank... August 2, 2021 Iridia to Use New Funds for the First... April 2, 2021 OmniSync Raises $1M in Recent Seed March 18, 2021 Meallogix Raises $1.7M in Pre-Series A Round March 18, 2021 Prometheus Biosciences Raises $190M March 15, 2021 Founders First to Fund 400 Diverse Founder Companies March 15, 2021 CourseKey Raises $9 Million in a Series B March 3, 2021 DTx Pharma Raises $100 Million in Series B March 2, 2021 JMI Equity closes their latest growth fund at... March 1, 2021 Workiz Raises $13 Million March 1, 2021 Leave a Comment Cancel Reply Save my name, email, and website in this browser for the next time I comment.